Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

436 PHENYTOIN
Reactions
Skin
Acne
(1993): Shah M+, Eur J Dermatol 3, 576
(1990): Grunwald MH+, Int J Dermatol 29, 559
(1983): Greenwood R+, Br Med J Clin Res Ed 287, 1669
(1980): Stankler L+, Br J Dermatol 103, 453 (neonatal)
Acute generalized exanthematous pustulosis (AGEP)
(2001): Burrow W, Jackson, MS (from Internet) (observation)
(1995): Moreau A+, Int J Dermatol 34, 263 (passim)
Angioedema
(1992): Schlaifer D+, Eur J Hematol 48, 274
Bullous dermatitis
(1988): Baird BJ+, Int J Dermatol 27, 170
Dermatomyositis
(1998): Dimachkie MM+, J Child Neurol 13, 577
Eosinophilic fasciitis
(1980): Buchanan RR+, J Rheumatol 7, 733
Epidermolysis bullosa
(1982): Bergfeld WF+, JAmAcadDermatol7, 275
Erythema multiforme
(2001): Bravo F, Lima, Peru (from Internet) (observation)
(1999): Marinella MA, Ann Pharmacother 33, 748
(1999): Micali G+, Pharmacotherapy 19, 223 (with cranial
irradiation)
(1995): Rodriguez-Castellanos M+, Arch Dermatol 131, 620
(1990): Giroud M+, Therapie (French) 45, 23
(1988): Delattre JY+, Neurology 38, 194
(1988): Shear NH+, J Clin Invest 82, 1826
(1986): Green ST, Clin Neuropharmacol 9, 561
(1985): Tucker MS+, J Am Osteopath Assoc 85, 511
Erythroderma
(1996): Chopra S+, Br J Dermatol 134, 1109
(1991): Yamashina T+, Nippon Shokakibyo Gakkai Zasshi
(Japanese) 88, 1269
(1983): Lillie MA+, Arch Dermatol 119, 415
Exanthems (6–71%)
(2004): Scheinfeld N, Expert Opin Drug Saf 3(6), 655
(2004): Singh G+, J Neurol Neurosurg Psychiatry 75(2), 331 (3
cases)
(2003): Misra UK+, Postgrad Med J 79(938), 703 (with
carbamazepine)
(2001): Hebert AA+, J Clin Psychiatry 62, 22
(2000): Cohen AD+, Isr Med Assoc J 1, 95
(1997): Hyson C+, Can J Neurol Sci 24, 245
(1996): Leong KP+, Asian Pac J Allergy Immunol 14, 65 (71.4%)
(1992): Tone T+, JDermatol19, 27
(1991): Pelekanos J+, Epilepsia 32, 554
(1988): Shear NH+, J Clin Invest 82, 1826
(1984): Chadwick D+, J Neurol Neurosurg Psychiatry 47, 642
(6%)
(1983): Rapp RP+, Neurosurgery 13, 272
Exfoliative dermatitis
(2004): Scheinfeld N, Expert Opin Drug Saf 3(6), 655
(2002): ten Holder SM+, Ann Pharmacother 36(1), 130
(1997): Westhoven GS+, Arch Dermatol 133, 494
(1996): Leong KP+, Asian Pac J Allergy Immunol 14, 65 (2.4%)
(1996): Sigurdsson V+, JAmAcadDermatol35, 53
(1989): Danno K+, JDermatol(Tokio) 16, 392
(1985): Matson JR+, Hum Pathol 16, 94
(1983): Rapp RP+, Neurosurgery 13, 272
Fixed eruption
(2004): Scheinfeld N, Expert Opin Drug Saf 3(6), 655
(2002): ten Holder SM+, Ann Pharmacother 36(1), 130
(1997): Chan HL+, JAmAcadDermatol36, 259
(1988): Baird BJ+, Int J Dermatol 27, 170 (bullous)
Hand–foot syndrome
(2003): Scheinfeld N, Dermatol Online J 9(3), 6
Heel pad thickening
Kaposi’s varicelliform eruption
(2006): Ajith C+, Int J Dermatol 45(12), 1452
Lichen planus
(1991): MacLeod SP+, Br Dent J 171, 237
Lichenoid eruption
(1992): Tone T+, JDermatol19, 27
Linear IgA dermatosis
(2004): Scheinfeld N, Expert Opin Drug Saf 3(6), 655
(2003): Avci O+, JAmAcadDermatol48(2), 299 (passim)
(2003): Tran D+, Australas J Dermatol 44(4), 284
(2002): Cohen LM+, JAmAcadDermatol46(2), S32 (passim)
(2000): Mofid MZ+, J Burn Care Rehabil 21(3), 246 (with
vancomycin)
(1998): Acostamadiedo JM+, JAmAcadDermatol38, 352
(1994): Kuechle MK+, JAmAcadDermatol30, 187
Lupus erythematosus
(2003): Scheinfeld N, Dermatol Online J 9(3), 6
(2002): Ross S+, Clin Exp Dermatol 27(6), 474
(1993): Drory VE+, Clin Neuropharmacol 16, 19 (passim)
(1988): Jiang M, Chung Kuo I Hsueh Ko Hsueh Yuan Hsueh Pao
(Chinese) 10, 379
(1985): Lovisetto P+, Recenti Prog Med (Italian) 76, 84
(1984): Wollina U, Z Gesamte Int Med (German) 39, 69
(1982): Gleichman H, Arthritis Rheum 25, 1387
(1981): Grossman J+, Arthritis Rheum 24, 927
Lupus syndrome
(2004): Scheinfeld N, Expert Opin Drug Saf 3(6), 655
Lymphoma (